Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial

By McCrindle B.W.   Ose L.   Marais D.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial

By Maria Morais-Socorro   Alvaro Cavalcanti Maciel   Rand Martins   Paulo Neto Francisco   Adriana Rezende   George Azevedo   Maria Almeida  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 483-487

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial

By Palomba Stefano  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3213-3219

Oxford University Press

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite